Deliveries are expected to start by the end of this year, the companies said. Reuters photo.
November 11
Pfizer Inc and German partner BioNTech SE said on Wednesday they had reached an agreement with the European Commission to supply up to 300 million doses of their experimental coronavirus vaccine.
Deliveries are expected to start by the end of this year, the companies said.
The companies said on Monday their COVID-19 vaccine was more than 90% effective based on initial trial results, and the European Commission had hours later said it would soon sign the contract with the companies.
The companies have a $1.95 billion contract with the U.S. government to deliver 100 million vaccine doses beginning this year.—Reuters
Most Read
Don't Miss
Top Stories
India, China on verge of reaching agreement to resolve border standoff in eastern Ladakh
Both sides will remove their tanks, artillery guns, and larg...
Govt brings news, films, audio-visual content on online platforms under I&B ministry
Online providers such as Netflix will also come under the mi...
SC grants interim bail to Arnab Goswami in abetment to suicide case
Says Bombay HC was in error in rejecting Goswami's applicati...
NDA overcomes stiff challenge to retain power in Bihar; Nitish to get fourth successive term
The ruling coalition won 125 seats in the 243-member state A...
Govt approves Rs 1.46 lakh more to boost manufacturing in 10 sectors
PLI scheme already on in three sectors at a cost of over Rs ...
